What is NDC 0005-0100?

0005-0100 is the product NDC for Trumenba (meningococcal group b vaccine), Neisseria meningitidis group b recombinant LP2086 a05 protein variant antigen 60 ug/.5mL; Neisseria meningitidis group b recombinant LP2086 b01 protein variant antigen 60 ug/.5mL injection, suspension, listed with the FDA by Wyeth Pharmaceutical Division of Wyeth Holdings LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Trumenba (Meningococcal group B vaccine).

What is the active ingredient?

Neisseria meningitidis group b recombinant LP2086 a05 protein variant antigen, Neisseria meningitidis group b recombinant LP2086 b01 protein variant antigen.

Wyeth Pharmaceutical Division of Wyeth Holdings LLC, NDC labeler code 0005. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Trumenba?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Trumenba NDC 0005-0100 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0005-0100Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00005-0100Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0005-0100-05	00005010005	5 SYRINGE in 1 CARTON (0005-0100-05) / .5 mL in 1 SYRINGE (0005-0100-01)Marketed from Nov 5, 2014
0005-0100-10	00005010010	10 SYRINGE in 1 CARTON (0005-0100-10) / .5 mL in 1 SYRINGE (0005-0100-01)Marketed from Nov 5, 2014

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trumenba
Generic name (nonproprietary): meningococcal group b vaccine
Active ingredients: Neisseria meningitidis group b recombinant LP2086 a05 protein variant antigen — 60 ug/.5mLNeisseria meningitidis group b recombinant LP2086 b01 protein variant antigen — 60 ug/.5mL
Dosage form: Injection, Suspension
Route: Intramuscular
Labeler: Wyeth Pharmaceutical Division of Wyeth Holdings LLCNDC labeler code 0005
Product type: Vaccine
Marketing category: BLA — Biologics License ApplicationApplication BLA 125549
Marketing start: Nov 5, 2014
Listing expires: Dec 31, 2027
Identifiers: Product ID 0005-0100_81783d36-a13f-4075-9962-8f45a9859b97SPL ID 81783d36-a13f-4075-9962-8f45a9859b97

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Immunization administration (CPT 90460–90474)

Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.

How CPT relates to drug billing

NDC on a medical claim

N400005010005 followed by a unit qualifier and the quantity

Package 00005-0100-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 0005-0100

What is NDC 0005-0100?: 0005-0100 is the product NDC for Trumenba (meningococcal group b vaccine), Neisseria meningitidis group b recombinant LP2086 a05 protein variant antigen 60 ug/.5mL; Neisseria meningitidis group b recombinant LP2086 b01 protein variant antigen 60 ug/.5mL injection, suspension, listed with the FDA by Wyeth Pharmaceutical Division of Wyeth Holdings LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Trumenba (Meningococcal group B vaccine).
What is the active ingredient?: Neisseria meningitidis group b recombinant LP2086 a05 protein variant antigen, Neisseria meningitidis group b recombinant LP2086 b01 protein variant antigen.
Who is the labeler?: Wyeth Pharmaceutical Division of Wyeth Holdings LLC, NDC labeler code 0005. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Trumenba?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Trumenba (Meningococcal group b vaccine) NDC 0005-0100